The application of these methods to colorectal cancer, together with methods to precisely ablate Lgr5+ cells in vivo [50], initiated a new era for the CSCs concept, releasing it from its dependency on serial transplantation as an operational definition, and leading to deep insights into the function of these cells in cancer progression. This evidence concerns the gene LGR5 and colorectal cancer.